Publications by authors named "Michael Mark"

Claim this Profile
F
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastases.
Lorenz Frehner, Sämi Schär, Stefanie Hayoz, Verena Petermichl, Philip Speicher, Michael Mark

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive frameworks for intraoperative surgical decision-making: A systematic scoping review.
Sanjay Subramanian, Mark Michael, Leif Berglund, Alice Chu, Per Jolbäck

Surgery· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Concurrent Neurophysiological Responses to Dynamic In-Motion Physical and Cognitive Functional Tasks in Division I Athletes.
Thomas Palmer, Bob Mangine, Audrey Hill-Lindsay, Joseph Clark, Bradley Jacobs, Michael Mark

Sports Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Multidisciplinary Tumor Board Adherence in Stage III Non-Small-Cell Lung Cancer Patients From a Large Multicenter Study.
Kira-Lee Koster, Sarvaganthasenay Yohasenan, Ahmet Samil Pakmak, Michael Mark, Yannis Metaxas, Markus Glatzer, Markus Joerger

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19).
Alfredo Addeo, Daniel Dietrich, Nicolas Mach, Michael Thomas Mark, Markus Joerger

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.
Dominic Schmid, Bettina Sobottka, Massimiliano Manzo, Marta Trüb, Katharina Leonards, Michael Mark

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment-A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01, 16/08, and 16/14: A Brief Report.
Sabine Raimann, Sämi Schär, Stefanie Hayoz, Matthias Guckenberger, Tobias Finazzi, Michael Mark

JTO Clin Res Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acidosis as a promising early indicator of mortality among point-of-care parameters and vital signs in non-traumatic critically ill patients.
Asen S Georgiev, Tim Filla, Janina Dziegielewski, Katharina Bandmann, Peter Kienbaum, Mark Michael

Scand J Trauma Resusc Emerg Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Typical causes and clinical presentations of traumatic and nontraumatic soft tissue and organ haemorrhage in emergency departments].
Mark Michael, Björn Hossfeld, Michael Bernhard

Radiologie (Heidelb)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study.
Laura Moliner, Núria Zellweger, Sabine Schmid, Martina Bertschinger, Christine Waibel, Michael Mark

JTO Clin Res Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland.
Tämer El Saadany, Judith Lupatsch, Michael Mark, Michaela Barbier, Tarun Mehra

Swiss Med Wkly· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to Write an Abstract.
Matthew H Meade, Mark Michael, Jamie Henzes, Ruchir Nanavati, Barrett Woods

Clin Spine Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.
Sabine Schmid, Lisa Holer, Katrin Gysel, Kira-Lee Koster, Sacha I Rothschild, Michael Mark

JTO Clin Res Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Task-Driven Neurophysiological qEEG Baseline Performance Capabilities in Healthy, Uninjured Division-I College Athletes.
Robert E Mangine, Thomas G Palmer, James A Tersak, Michael Mark, Joseph F Clark

Int J Sports Phys Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Fragility Index: Understanding Its Application in Clinical Research.
Matthew H Meade, Levi Buchan, Mark Michael, Barrett Woods

Clin Spine Surg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retrospective analysis of the resuscitation room management of nontraumatic critically ill children in a university emergency department (OBSERvE-DUS-PED study)].
Claudia Priebe, Hans Martin Bosse, Mark Michael, Olaf Picker, Michael Bernhard

Anaesthesiologie· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study.
Michael Mark, Alfonso Rojas Mora, Thomas Winder, Anastasios Stathis, Andreas Jakob

Bone Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Development of violence-associated penetrating trauma in the Düsseldorf metropolitan region over a 5-year period (GewPen study)].
Jutta Schürmann, Mark Michael, Olaf Picker, Dan Bieler, Kalle Heitkötter

Anaesthesiologie· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison.
Kristen Johnson, Barbara Stoffel, Michael Schwitter, Stefanie Hayoz, Alfonso Rojas Mora, Michael Mark

Support Care Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer.
Enriqueta Felip, Giulio Metro, Daniel S W Tan, Juergen Wolf, Michael Mark

Lung Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference Managers.
Matthew Meade, William DiCiurcio, Tyler Radack, Mark Michael, Barrett Woods

Clin Spine Surg· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of noise-induced hearing loss in the spine surgeon.
Matthew H Meade, Stephanie A Kwan, Mark E Michael, Nicholas J Minissale, Levi Buchan

N Am Spine Soc J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
Michael Mark, Patrizia Froesch, Katrin Gysel, Sacha I Rothschild, Alfredo Addeo, Markus Joerger

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survey on the presence of palliative care knowledge and palliative care structures in German emergency departments].
Lennert Böhm, Jacqueline Schwartz, Mark Michael, Eva Diehl-Wiesenecker, Michael Bernhard

Anaesthesiologie· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns.
Sonia Samuel, Mark Michael, Micheal Tadros

World J Clin Cases· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis